お知らせ

2018/04/16

PharmaBio invited Dr. Shohachi Nakajima, the former CMC development manager at Kyowa Hakko Kirin Co., as General Production Manager and CMC Development Manager at PharmaBio Corporation

PharmaBio (hereinafter PharmaBio; Headquarters: Nagoya City, Aichi Prefecture; Representative Director: Hitoshi Kusano) is delighted to announce the appointment of Dr. Shohachi Nakajima, the former CMC development manager at Kyowa Hakko Kirin Co., Ltd., as General Production Manager & CMC Development Manager at PharmaBio effected on April 13th.

PharmaBio provides development and manufacturing support in any stages from the early stage to products after marketing approval, which would be able to respond to a wide range of customer needs. Dr. Nakajima’s extensive knowledge held at Kyowa Hakko Kirin Co., Ltd., a leading biopharmaceutical manufacturing distributor in Japan, will contribute to the further improvement of the quality of our services and we are convinced that it will contribute to those who waiting for high quality products.

【About Dr. Shohachi Nakajima】
Bachelor’s and Master’s degree in Agriculture at Gifu University, and Doctor in Agriculture at University of Tokyo. Joined KIRIN, engaged in pharmaceutical development research. Served leading position from development of biopharmaceuticals to manufacture of market products and establishment of pharmaceutical manufacturing plants at Kirin Pharma Co., Ltd. and Kyowa Hakko Kirin Co., Ltd. After retiring Takasaki facility manager in Kyowa Hakko Kirin, he served as GMP facility manager at Manufacturing Technology Association of Biologics in Kobe.

Manufacturing of biopharmaceuticals, establishment of GMP quality system, establishment of pharmaceutical manufacturing plant.

【About PharmaBio】
PharmaBio, as Japan’s first contract development and manufacturing organization specialized in cell and tissue-derived pharmaceuticals, provides pharmaceutical development solution business and contract manufacturing of cell and tissue based products and which achieves high quality and high effectiveness in manufacturing development process.
In addition, we will respond to the development manufacturing consignment for Global Study through a service provision alliance with Cell Therapies pty. Ltd., which is known as leading CDMO in the Asia Pacific region in the cell / tissue derived medicine field.

PhamraBio Corporation Administrative division
Yuki Takahashi / +81-3-6205-4101/ hq_kanri@pharmabio.co.jp


To view a PDF version of this article please click here:

ご相談ください

ファーマバイオの製品やサービスおよび、開催予定の展示会やセミナーに関するご質問を承ります。お気軽にお問い合わせください。

電話:03-6205-4101
ファックス: 03-6205-4102
受付時間: 平日9:00~17:30